Derangements in purine nucleotide synthesis and interconversion are associated with a number of clinical disorders. Increased puring biosynthesis leads to overproduction of uric acid, and the resultant hyperuricemia and hyperuricosuria may cause gout and/or renal calculi. Enzymatic defects in the interconversion pathway referred to as the purine nucleotide cycle have been associated with a clinical myopathy. The objective of this proposal is to define the mechanisms which control the rate of purine nucleotide synthesis and hence uric acid production and to better understanding the role of the purine nucleotide cycle in skeletal muscle function.
One specific aim i s to determine what regulates the activity of PP-ribose-P amidotransferase, amidophosphoribosyltransferase, in human cells. The following hypothesis will be tested in these studies: oxygen inactivation of amidophosphoribosyltransferase, which is an iron-sulfur, oxygen-sensitive enzyme, is the initial step leading to degradation of this protein and variability in the sensitivity of this enzyme to oxygen inactivation regulates the activity of this enzyme in the cell. Radio-immunoprecipitation studies are described to define the rate of inactivation and degradation of this enzyme under different growth conditions. The other specific aim is to determine what controls the developmental expression of the purine nucleotide cycle enzymes during myocyte differentiation, what controls flux through this cycle, and what are the physiological consequences of distruption of this cycle. Patients with inherited enzyme defects, i.e. AMP deaminase deficiency, and animal models (rats) of nucleotide cycle disorders will be evaluated for muscle performance, as well as the biochemical basis for muscle dysfunction. Myocyte cell culture models will be used to study the expression of muscle specific isozymes of the purine nucleotide cycle enzymes during differentiation. Intracellular protein turnover and in vitro translation techniques will be used to determine the basis for the increase in activity of the muscle specific isozymes of the purine nucleotide cycle enzymes during differentiation. Studies with purified nucleotide cycle enzymes and contractile proteins will determine if binding of the nucleotide cycle enzymes to contractile proteins plays a role in controlling the activity of these enzymes in the myocyte.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK012413-20
Application #
3224884
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1979-05-01
Project End
1989-04-30
Budget Start
1987-05-01
Budget End
1988-04-30
Support Year
20
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Loh, E; Rebbeck, T R; Mahoney, P D et al. (1999) Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99:1422-5
Hisatome, I; Morisaki, T; Kamma, H et al. (1998) Control of AMP deaminase 1 binding to myosin heavy chain. Am J Physiol 275:C870-81
Morisaki, H; Morisaki, T; Newby, L K et al. (1993) Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest 91:2275-80
Morisaki, T; Holmes, E W (1993) Functionally distinct elements are required for expression of the AMPD1 gene in myocytes. Mol Cell Biol 13:5854-60
Sabina, R L; Fishbein, W N; Pezeshkpour, G et al. (1992) Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 42:170-9
Morisaki, T; Gross, M; Morisaki, H et al. (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A 89:6457-61
Mineo, I; Holmes, E W (1991) Exon recognition and nucleocytoplasmic partitioning determine AMPD1 alternative transcript production. Mol Cell Biol 11:5356-63
Mineo, I; Clarke, P R; Sabina, R L et al. (1990) A novel pathway for alternative splicing: identification of an RNA intermediate that generates an alternative 5' splice donor site not present in the primary transcript of AMPD1. Mol Cell Biol 10:5271-8
Moseley, W S; Morisaki, T; Sabina, R L et al. (1990) Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. Genomics 6:572-4
Morisaki, T; Sabina, R L; Holmes, E W (1990) Adenylate deaminase. A multigene family in humans and rats. J Biol Chem 265:11482-6

Showing the most recent 10 out of 12 publications